TH — Theratechnologies Balance Sheet
0.000.00%
- CA$177.94m
- CA$241.68m
- $85.87m
- 34
- 52
- 98
- 65
Annual balance sheet for Theratechnologies, fiscal year end - November 30th, USD millions except per share, conversion factor applied.
2020 November 30th | 2021 November 30th | 2022 November 30th | 2023 November 30th | 2024 November 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 20.8 | 40.4 | 33.1 | 40.4 | 9.62 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 13.2 | 10.9 | 12.3 | 13.6 | 15.6 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 64.8 | 91.9 | 73.4 | 63.3 | 44 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 3.48 | 2.85 | 3.09 | 1.98 | 1.26 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 100 | 119 | 93.3 | 77.8 | 53.3 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 41.9 | 45.1 | 114 | 47.3 | 36.9 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 96.9 | 101 | 116 | 98.6 | 78.6 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 3.22 | 17.8 | -22.6 | -20.9 | -25.3 |
Total Liabilities & Shareholders' Equity | 100 | 119 | 93.3 | 77.8 | 53.3 |
Total Common Shares Outstanding |